Drug Interactions between Eliquis and polyethylene glycol 3350 with electrolytes
This report displays the potential drug interactions for the following 2 drugs:
- Eliquis (apixaban)
- polyethylene glycol 3350 with electrolytes
Interactions between your drugs
There were no interactions found in our database between Eliquis and polyethylene glycol 3350 with electrolytes - however, this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.
- Eliquis is in the drug class factor Xa inhibitors.
- Eliquis is used to treat the following conditions:
- Deep Vein Thrombosis
- Deep Vein Thrombosis Prophylaxis after Hip Replacement Surgery
- Deep Vein Thrombosis Prophylaxis after Knee Replacement Surgery
- Deep Vein Thrombosis, Prophylaxis
- Prevention of Thromboembolism in Atrial Fibrillation
- Pulmonary Embolism
- Thromboembolic Stroke Prophylaxis
- Venous Thromboembolism
polyethylene glycol 3350 with electrolytes
- Polyethylene glycol 3350 with electrolytes is a member of the drug class laxatives.
- Polyethylene glycol 3350 with electrolytes is used to treat the following conditions:
Drug and food interactions
polyethylene glycol 3350 with electrolytes food
Applies to: polyethylene glycol 3350 with electrolytes
Oral medications may not be properly absorbed when they are taken within one hour before starting polyethylene glycol 3350 with electrolytes for bowel cleansing. Talk to your doctor or pharmacist to see if you should adjust the dosing schedule of your other medications before you begin bowel cleansing treatment. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No interaction information available.|